title: Diffuse systemic large B-cell lymphoma with secondary skin involvement.
authors.affiliation: Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España. Electronic address: clloretruiz@gmail.com.
authors.forename: C
authors.initials: C
authors.lastname: Lloret-Ruiz
authors.affiliation: Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España.
authors.forename: P
authors.initials: P
authors.lastname: Molés-Poveda
authors.affiliation: Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España.
authors.forename: N
authors.initials: N
authors.lastname: Barrado-Solís
authors.affiliation: Servicio de Dermatología, Hospital Arnau de Vilanova, Valencia, España.
authors.forename: E
authors.initials: E
authors.lastname: Gimeno-Carpio
mesh_terms: D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001402:B-Lymphocytes / Q000737:chemistry / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis; D001706:Biopsy; D001853:Bone Marrow / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D064147:Febrile Neutropenia / Q000139:chemically induced; D006801:Humans; D007668:Kidney / Q000473:pathology; D007866:Leg; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000473:pathology*; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab / Q000008:administration & dosage; D012867:Skin / Q000473:pathology*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014408:Biomarkers, Tumor; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone